CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

A PureTech startup banks $180M for a new IPF drug

Positive
AI Analysis

Summary

A PureTech startup has secured $180 million in funding for development of a new idiopathic pulmonary fibrosis (IPF) drug.

Importance:5/10
Sentiment:
0.60
IPFfundingstartupPureTech
Related Companies

Read the original article

Published by yahoo_finance on July 2, 2026 11:04 AM

Read Original